rumor
    rumor
    • Screeners
    • Heatmaps
    • Charts
    • News
    • Documentation
    • Pricing
    • FAQ
    You're viewing limited data.
    Log inSign up

    Sign up

    24 hours of full access, free. No credit card.

    Log inPricing
    1 asset

    Market news

    TypeAll
    SortNewest
    Assets
    GYRE
    Type
    TypeAll
    All
    Sort
    SortNewest
    Newest

    Filter by asset

      Gyre Therapeutics earnings beat by $0.03, revenue topped estimates
      Nov 6Investing.comGYRE
      Gyre Therapeutics, Inc. (GYRE) Tops Q3 Earnings and Revenue Estimates
      Nov 6Yahoo FinanceGYRE
      IDEXX Laboratories, Perion Network, TAT Technologies And Other Big Stocks Moving Higher On Monday
      Nov 2BenzingaGYREIDXXPERITATT
      Incyte (INCY) Reports Q3 Loss, Beats Revenue Estimates
      Oct 29Yahoo FinanceGYRE
      Analysts Offer Insights on Healthcare Companies: Rezolute (RZLT), Actinium Pharmaceuticals (ATNM) and Gyre Therapeutics (GYRE)

      Tipranks Press Release.

      Oct 6The Globe and MailGYRE
      Gyre Therapeutics at Morgan Stanley conference: cash flow funds pipeline
      Sep 16Investing.comGYREMS
      Gyre Therapeutics to Participate in Upcoming September Investor Conferences

      SAN DIEGO, Sept. 03, 2026 (GLOBE NEWSWIRE) -- Gyre Therapeutics, Inc. (Gyre, Gyre Therapeutics or the Company) (Nasdaq: GYRE), an innovative, commercial-stage biopharmaceutical company with operations in the United States and China, today announced that Company management will participate in the Cantor Global Healthcare Conference and the Morgan Stanley Healthcare Conference, both being held this month in New York, NY. Information about both conferences is below: Cantor Global Healthcare Confere

      Sep 3Yahoo FinanceGYRE
      Gyre Therapeutics Highlights Capital-Efficient Global Development Strategy

      Detailed price information for Gyre Therapeutics Inc (GYRE-Q) from The Globe and Mail including charting and trades.

      Sep 2The Globe and MailGYRE
      Gyre Therapeutics unveils capital-efficient global development strategy

      Detailed price information for Gyre Therapeutics Inc (GYRE-Q) from The Globe and Mail including charting and trades.

      Aug 27The Globe and MailGYRE

      This is the newest page. Registered accounts read further back.